Cargando…

Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations

SIMPLE SUMMARY: Carriers of germline BRCA1/2 pathogenic variants are at increased risk of developing BRCA-associated malignancies (breast, ovarian, prostate and pancreatic cancer), which are responsive to treatment with poly (adenosine phosphate-ribose) polymerase inhibitors (PARPi) and platinum-bas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arnon, Johnathan, Tabi, Michael, Rottenberg, Yakir, Zick, Aviad, Blumenfeld, Philip, Hamburger, Tamar, Pikarsky, Eli, Avraham, Eti, Levine, Leeby, Popovtzer, Aron, Yablonski-Peretz, Tamar, Kadouri, Luna, Nechushtan, Hovav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571558/ https://www.ncbi.nlm.nih.gov/pubmed/37835426 http://dx.doi.org/10.3390/cancers15194733

Ejemplares similares

Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations
por: Nechushtan, Hovav, et al.
Publicado: (2009)

Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients
por: Zick, Aviad, et al.
Publicado: (2017)

Breast Cancer with Low Recurrence Score on Oncotype DX(©): Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation
por: Zarbiv, Yonaton, et al.
Publicado: (2022)

Potential Refinement of Recurrence Score by pSTAT3 Status
por: Grinshpun, Albert, et al.
Publicado: (2022)

Temporal trends of geographic variation in mortality following cancer diagnosis: a population-based study
por: Rottenberg, Yakir, et al.
Publicado: (2019)

Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes
por: Maoz, Myriam, et al.
Publicado: (2019)

Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes
por: Maoz, Myriam, et al.
Publicado: (2020)

“High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis”
por: Shraga, Shay, et al.
Publicado: (2021)

Clinical course and outcome of patients with high-level microsatellite instability cancers in a real-life setting: a retrospective analysis
por: Halpern, Naama, et al.
Publicado: (2017)

SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-γ, and Point Mutation in the Transcription Intermediary Factor 1-γ Coding Gene: A Case Report
por: Arnon, Johnathan, et al.
Publicado: (2021)

Intratumoral immune-biomarkers and mismatch repair status in leiyomyosarcoma -potential predictive markers for adjuvant treatment: a pilot study
por: Cohen, Jonathan E., et al.
Publicado: (2018)

A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy
por: Golan, Shay, et al.
Publicado: (2023)

Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data
por: Dudnik, Elizabeth, et al.
Publicado: (2021)

New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer
por: Nisman, Benjamin, et al.
Publicado: (2016)

Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma
por: Boulos, Suliman, et al.
Publicado: (2017)

Correction: Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma
por: Boulos, Suliman, et al.
Publicado: (2018)

Liquid First Is “Solid” in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing
por: Sehayek, Or, et al.
Publicado: (2022)

A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer
por: Kadouri, Luna, et al.
Publicado: (2007)

SYK expression level distinguishes control from BRCA1-mutated lymphocytes
por: Zahavi, Tamar, et al.
Publicado: (2018)

Heparanase augments insulin receptor signaling in breast carcinoma
por: Goldberg, Rachel, et al.
Publicado: (2016)

Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients
por: Sivan, Sapoznik, et al.
Publicado: (2012)

Role of Nudt2 in Anchorage-Independent Growth and Cell Migration of Human Melanoma
por: Hidmi, Sana’, et al.
Publicado: (2023)

Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells
por: Granit Mizrahi, Avital, et al.
Publicado: (2023)

Rapid Classification of Sarcomas Using Methylation Fingerprint: A Pilot Study
por: Iluz, Aviel, et al.
Publicado: (2023)

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers
por: Kadouri, L, et al.
Publicado: (2008)

Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review
por: Halpern, Naama, et al.
Publicado: (2020)

VERO cells harbor a poly-ADP-ribose belt partnering their epithelial adhesion belt
por: Lafon-Hughes, Laura, et al.
Publicado: (2014)

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers
por: Kadouri, L, et al.
Publicado: (2004)

Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients
por: Horesh, Adi, et al.
Publicado: (2023)

Geriatric patient-centered care during the COVID-19: Provision of interactions vs. the imposition of isolation
por: Rottenberg, Yakir, et al.
Publicado: (2020)

Predictors of death at home among cancer patients in Israel: a population-based study
por: Rottenberg, Yakir, et al.
Publicado: (2021)

Short report: Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study
por: Makranz, Chen, et al.
Publicado: (2023)

Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
por: Lotem, Michal, et al.
Publicado: (2016)

Genome-Wide Analysis of Androgen Receptor Targets Reveals COUP-TF1 as a Novel Player in Human Prostate Cancer
por: Perets, Ruth, et al.
Publicado: (2012)

Phosphate-Trapping Liposomes for Long-Term Management of Hyperphosphatemia
por: Tzror-Azankot, Chen, et al.
Publicado: (2022)

Human T Cell Crosstalk Is Induced by Tumor Membrane Transfer
por: Uzana, Ronny, et al.
Publicado: (2015)

Ribose and Non-Ribose A2A Adenosine Receptor Agonists: Do They Share the Same Receptor Recognition Mechanism?
por: Bolcato, Giovanni, et al.
Publicado: (2022)

Antibody Delivery into the Brain by Radiosensitizer Nanoparticles for Targeted Glioblastoma Therapy
por: Gal, Omer, et al.
Publicado: (2022)

Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma
por: Nahmias Blank, Daniela, et al.
Publicado: (2022)

Synthesis of Terminal Ribose Analogues of Adenosine 5′-Diphosphate Ribose as Probes for the Transient Receptor Potential Cation Channel TRPM2
por: Baszczyňski, Ondřej, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qbp7ptas1ihf4l7r3qgm8365mq